Munafa Stock Market Course + Intraday & FNO calls 
Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Karyopharm Therapeutics (KPTI)
Technical Analysis Report for USA stock KPTI Karyopharm Therapeutics. Dated: 30 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock KPTI Karyopharm Therapeutics then click here. or read Experts views on Karyopharm Therapeutics or Forecast & share price targets of Karyopharm Therapeutics
Karyopharm Therapeutics Opened at 6.66 and Closed at: 6.52, which is -1.69% of previous session's close. It moved within a range of 6.42 and 6.80
The session was a Bearish session with an average volume of 267900, which is 34.04% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 8 days back on short term averages
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 6.28 and resistance for tomorrow is 6.66
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 6.36, 6.2 resistance for tomorrow's hourly charts is 6.74, 6.96
10 Day SMA for Karyopharm Therapeutics (KPTI) is 6.56 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Karyopharm Therapeutics (KPTI) is 7.11 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Karyopharm Therapeutics (KPTI) is 6.66 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 6.35 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Karyopharm Therapeutics is 5.72 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Karyopharm Therapeutics is at 7.11 and 200 DMA is at 5.72, while 50 DMA and 100 DMA are at 6.66 and 6.35 respectively
Karyopharm Therapeutics (KPTI) moving average of 20 SMA is at 7.11 and 20 EMA is at 6.87
| Date | Closing Price | 20 SMA | 20 EMA |
| 30 Fri Jan | 6.52 | 7.11 | 6.87 |
| 29 Thu Jan | 6.63 | 7.15 | 6.91 |
| 28 Wed Jan | 6.92 | 7.19 | 6.94 |
| 27 Tue Jan | 7.05 | 7.21 | 6.94 |
| 26 Mon Jan | 6.65 | 7.23 | 6.93 |
| 23 Fri Jan | 6.59 | 7.27 | 6.96 |
Karyopharm Therapeutics (KPTI) moving average of 50 SMA is at 6.66 and 50 EMA is at 6.72
| Date | Closing Price | 50 SMA | 50 EMA |
| 30 Fri Jan | 6.52 | 6.66 | 6.72 |
| 29 Thu Jan | 6.63 | 6.65 | 6.73 |
| 28 Wed Jan | 6.92 | 6.63 | 6.73 |
| 27 Tue Jan | 7.05 | 6.6 | 6.72 |
| 26 Mon Jan | 6.65 | 6.57 | 6.71 |
| 23 Fri Jan | 6.59 | 6.55 | 6.71 |
Karyopharm Therapeutics (KPTI) moving average of 100 SMA is at 6.35 and 100 EMA is at 6.36
| Date | Closing Price | 100 SMA | 100 EMA |
| 30 Fri Jan | 6.52 | 6.35 | 6.36 |
| 29 Thu Jan | 6.63 | 6.35 | 6.36 |
| 28 Wed Jan | 6.92 | 6.35 | 6.35 |
| 27 Tue Jan | 7.05 | 6.35 | 6.34 |
| 26 Mon Jan | 6.65 | 6.35 | 6.33 |
| 23 Fri Jan | 6.59 | 6.35 | 6.32 |
Karyopharm Therapeutics (KPTI) moving average of 200 SMA is at 5.72 and 200 EMA is at 5.52
| Date | Closing Price | 200 SMA | 200 EMA |
| 30 Fri Jan | 6.52 | 5.72 | 5.52 |
| 29 Thu Jan | 6.63 | 5.71 | 5.51 |
| 28 Wed Jan | 6.92 | 5.69 | 5.5 |
| 27 Tue Jan | 7.05 | 5.68 | 5.49 |
| 26 Mon Jan | 6.65 | 5.67 | 5.47 |
| 23 Fri Jan | 6.59 | 5.65 | 5.46 |
Novo Nordisk has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Novo Nordisk, about 22.76% more returns!
Quest Diagnostics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Quest Diagnostics, about 16.94% more returns!
Chemed Corp has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Chemed Corp, about 10.11% more returns!
Sutro Biopharma has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Sutro Biopharma, about 45.73% more returns!
Repligen Corporation has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Repligen Corporation, about 0.21% more returns!
Opko Health has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Opko Health, about 8.53% more returns!
Neurocrine Biosciences has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 6.09% more returns!
Orthopediatrics Corp has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 8.75% more returns!
Immucell Corporation has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Immucell Corporation, about 11.01% more returns!
Karyopharm Therapeutics has performed better than Gossamer Bio in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Karyopharm Therapeutics has performed better than Galectin Therapeutics in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Fennec Pharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 8.15% more returns!
Karyopharm Therapeutics has performed better than Evolus Inc in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Dariohealth Corp has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Dariohealth Corp, about 4.57% more returns!
Cue Biopharma has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Cue Biopharma, about 6.38% more returns!
Karyopharm Therapeutics has performed better than Cellectis S in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Biolinerx has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Biolinerx, about 20.39% more returns!
Adma Biologics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Adma Biologics, about 6.08% more returns!
Karyopharm Therapeutics Technical analysis of indicators
Price action analysis of Karyopharm Therapeutics (KPTI) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Karyopharm Therapeutics in short term and the sell signal is strong.
Karyopharm Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Karyopharm Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Karyopharm Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.54 and Karyopharm Therapeutics KPTI stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Karyopharm Therapeutics KPTI stock. Volume based technical analysis of Karyopharm Therapeutics KPTI stock is negative.
Karyopharm Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock KPTI Karyopharm Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And KPTI Experts View which covers a lot of information including buying and selling signals
KPTI future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Karyopharm Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
